Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This is a Phase 1/2 Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration (AMD). This is a multicenter study, which will be conducted in two phases and will enroll up to a total of 63 subjects.
Epistemonikos ID: 9e0f01d938ae31c07b984d55c869bfd318acae4a
First added on: May 15, 2024